Literature DB >> 517859

HLA-Bw15 and tuberculosis in a North American black population.

L I Al-Arif, R A Goldstein, L F Affronti, B W Janicki.   

Abstract

Peripheral blood lymphocytes from 60 black patients with Mycobacterium tuberculosis disease proved by culture and 100 healthy black persons were HLA phenotyped using a standard lymphocytotoxicity test. Statistical analysis of the results showed that only Bw15 antigen had a significantly increased frequency among patients with tuberculosis when they were compared to healthy persons. Furthermore, examination of disease manifestations among patients with tuberculosis demonstrated that patients with Bw15 had significantly more far-advanced pulmonary disease with cavitation than did patients without Bw15. These observations suggest that Bw15 may influence both susceptibility to tuberculosis and the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517859     DOI: 10.1164/arrd.1979.120.6.1275

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Deficient immune interferon production in tuberculosis.

Authors:  J K Onwubalili; G M Scott; J A Robinson
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  H.L.A. typing in a family with sarcoidosis and tuberculosis.

Authors:  P Manning; L Clancy
Journal:  Ir J Med Sci       Date:  1987-01       Impact factor: 1.568

Review 3.  Human leukocyte antigens (HLA) and mycobacterial disease.

Authors:  R R de Vries; T H Ottenhoff; W C van Schooten
Journal:  Springer Semin Immunopathol       Date:  1988

Review 4.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

Review 5.  Miliary tuberculosis: A new look at an old foe.

Authors:  Surendra K Sharma; Alladi Mohan; Animesh Sharma
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.